Objectives. We examined reasons for and barriers to participating in HIV voluntary counseling and testing for Asian/Pacific Islander (A/PI) men who have sex with men (MSM) in the U.S.
Men who have sex with men (MSM) continue to have the highest human immunodeficiency virus (HIV) infection rates in the U.S., with MSM of color being disproportionately affected by the disease. 1 Compared with MSM of other racial/ethnic groups, Asian/Pacific Islander (A/PI) MSM have the highest proportion of acquired immunodeficiency syndrome (AIDS) cases, with a majority of them being non-U.S.-born. 2, 3 Research attributes this disparity to low testing rates [4] [5] [6] and late diagnosis, which are often associated with advanced AIDS symptoms 7 as well as late entry into care. 8, 9 Voluntary counseling and testing (VCT) has been a successful standard of HIV prevention since the emergence of the epidemic in the U.S. and other developed countries. [10] [11] [12] [13] [14] This prevention strategy has also been adopted by other developing countries. 15 Nonetheless, the uptake of VCT is still less then optimal. 16 For example, combining multiple datasets from the 2000 to 2005 National Health Interview Surveys, Ostermann et al. found little change in lifetime and past year testing, respectively. However, individuals who perceived higher risks of contracting HIV were more likely to plan for and engage in actual HIV testing. 17 Meanwhile, the literature consistently indicates that the stigma of having HIV and/or being a sexual minority is a major barrier or determinant for efficacious or effective prevention, intervention, and treatment, especially among marginalized, vulnerable, or underserved populations. 18 Using a qualitative methodology (i.e., in-depth interview), Yoshioka and Schustack found three major barriers to disclosure of HIV status among a sample of HIV-positive men of Asian descent in the U.S.: (1) protection of family from shame, (2) protection of family from obligation to help, and (3) avoidance of communication regarding highly personal information (including same-sex sexual orientation). 19 Collectively, these articles in the literature lend to the postulation that the effectiveness of VCT hinges on at-risk individuals having well-informed information regarding the attitudes, beliefs, and practices of HIV testing. 20 Although a small number of cross-sectional studies have been conducted, 6, 7, 9, 21 little to no national data are available addressing HIV testing and HIV management among A/PI MSM. To that end, we used data from a national study of HIV prevention to describe and examine (1) reasons for and barriers to HIV testing among a national sample of A/PI MSM, and (2) care and treatment among those who have tested HIV-positive in the past, by nativity (U.S.-born vs. non-U.S.-born).
MeTHodS

Participant recruitment and enrollment
We used data collected between June 2007 and August 2009 from a national study that used a communitybased participatory research design known as Men of Asia Testing for HIV (MATH). Eligible participants included men aged 18 years who self-identified as A/PI ethnicity; had sex with another man in the last 12 months; had resided in the targeted city in the last six months; were able to provide verbal and written informed consent in English, Chinese, or Vietnamese; and were willing to participate in HIV screening and confirmatory testing. Men were recruited from seven community-based organizations (CBOs) in seven metropolitan cities (Boston, Los Angeles, New York City, Oakland, Philadelphia, San Francisco, and San Jose). Two of the CBOs (in Oakland and San Jose) are primary community health-care centers serving A/PIs in their catchment areas; HIV prevention is a recent (since 2004) small addition (e.g., less than two full-time HIV prevention staff per CBO) to their services. The CBO in San Francisco is the largest AIDS service organization (ASO) targeting A/PIs in the U.S., although in the last 10 years it has expanded to include other sexual health-related services targeting this population. Similar to the one in San Francisco, the rest of the CBOs (in Boston, Los Angeles, New York City, and Philadelphia) started out as ASOs, but have expanded their services to include a variety of programs, such as language assistance and transgender programs.
Broad-based recruitment strategies were used to refer participants into the study, including (1) standard outreach, such as distributing study flyers and postcards in gay bars, venues, and public sex areas;
(2) announcements via mainstream (e.g., gay pride) and ethnic-specific gay events; and (3) announcements via the Internet. In short, participants in this study (n5445)constituted a purposive (i.e., deliberate and nonrandom) convenience sample of people who met the inclusion criteria. After being referred, participants scheduled a time to come to their study site. When participants arrived at their study site, they were guided through an informed consent process before all data were collected in a private office dedicated to the project.
HIV screening and confirmatory testing
A certified HIV prevention counselor initially screened all participants for HIV using OraQuick ® (OraSure Technologies, Inc., Bethlehem, Pennsylvania). Those who screened HIV-negative were given additional HIV prevention messages. Those who initially screened HIV-positive were offered a confirmatory test. For those with positive confirmatory Western blots, appropriate referrals to treatment and care were made for their HIV diagnosis.
Psychosocial and behavioral assessment: variables
While waiting for the HIV screening result, the participant completed a self-administered psychosocial and behavioral assessment (in English, Chinese, or Vietnamese), which took about 30-45 minutes to complete. The assessment contained four major sections: (1) demographic characteristics of the participants (e.g., age, ethnicity, place of birth, sexual orientation, and medical insurance); (2) psychosocial variables (e.g., degree of outness about same-sex sexual orientation to families, friends, and/or coworkers); (3) sexual health (e.g., sexual communications); and (4) sexual behaviors and HIV-related practices (e.g., unprotected anal sex, HIV testing, and HIV management).
For this study, in addition to demographic characteristics, we were interested in three major categories of variables: HIV testing behaviors, reasons for and barriers to HIV testing, and HIV management behaviors. For the HIV testing behaviors variable, participants were asked to self-report if they had ever been tested for HIV. Regardless of self-reported status, all participants underwent HIV screening and, if appropriate, confirmatory testing as described. For the reasons for and barriers to HIV testing variable, participants were asked to check off a list of reasons for HIV testing (e.g., "I started having sex with a new partner") and barriers HIV testing (e.g., "I am afraid that the result might be positive"). For the HIV management variable, individuals who self-reported being HIV-positive with confirmed HIV-positive status in the present study were asked about how they managed their HIV condition. Specifically, care was measured by asking if the individual was being seen by a medical doctor for his HIV condition. Treatment was measured by asking if the individual was presently on any type of HIV medication (e.g., highly active antiretroviral therapy). In addition, all were asked if they had ever been diagnosed with AIDS.
Analysis
Data were stratified by nativity (i.e., non-U.S.-born vs. U.S.-born) given that more than two-thirds of A/PIs in the U.S. are non-U.S.-born. 22 Descriptive statistics were used to summarize the sample, with appropriate two-tailed significance tests; p0.05 was considered statistically significant. For the first study aim, reasons for and barriers to HIV testing were first grouped into meaningful thematic categories (e.g., disclosure) and then ranked by degree of endorsement, where 1 5 most important and 5 5 least important. This process was independently performed by three research staff for consensus. Significance tests were not performed on these groupings and rankings. For the second study aim, results of types of HIV management (e.g., being seen by a doctor or taking HIV medications) were presented. We used Fisher's exact test and the Student's t-test, respectively, for categorical variables and continuous variables comparing non-U.S.-born and U.S.-born individuals.
ReSULTS
Demographic characteristics of the sample are summarized in Table 1 . A roughly equal number of non-U.S.-born (52.3%) and U.S.-born (46.5%) participants enrolled in the study. Given that more than 66% of self-identified A/PIs in the U.S. are non-U.S.-born, our sample was close to representing the distribution of this population. 22 Non-U.S.-born participants were significantly (p50.01) more likely to be recruited from the East Coast (15.9%) than U.S.-born participants (8.2%). Those who self-identified as Southeast Asian were significantly more likely to be non-U.S.-born than U.S.-born (43.2% vs. 28.3%), while those who selfidentified as Asian American were significantly more likely to be U.S.-born rather than non-U.S.-born (32.7% vs. 22.7%, p50.01). These findings are consistent with the national demographic profiles of A/PIs. 22 Three demographic characteristics-age, age at first intimate physical contact with a man, and medical insurance-trended toward statistical significance. Non-U.S. 23 Men who self-reported being HIV-negative all screened negative. These results yielded a crude HIV prevalence of 5.6% for the total sample (data not shown).
For the first study aim, participants were asked to check off a list of reasons (all that apply) regarding their motivations for and barriers to HIV testing (Tables 2a and 2b ). Both types of participants-naïve testers (those testing for the first time in this study) and non-naïve testers (those who had tested before)ranked perception of risks as the number one reason for their testing behaviors. That is, naïve testers cited low-to-no risks (e.g., "I am not worried about getting HIV") for their prior nontesting behavior, whereas non-naïve testers cited having high-risk behaviors ("I had unprotected anal sex") for their testing behavior.
Other reasons cited by naïve testers included laziness (e.g., "I have been too lazy or have been putting it off"), structural barriers (e.g., "I don't know where to go to get tested" or "I can't afford to get tested"), fear of disclosure (e.g., "I am afraid my parents or family will find out the results"), and fear of being HIV-positive. Among MSM who had previously been tested, other reasons for testing behavior included relationship involvement, personal intention, cues to action (e.g., doctor recommendation), research study involvement, or employment requirements. Though cues to action, such as a doctor recommendation, ranked as the fourth reason overall for HIV testing, this reason was consistent with past research; A/PIs in the U.S. tend to first find out their HIV/AIDS status when they are sick, and testing-often for the first time ever-is conducted per their doctor's request. 8 With respect to the second study aim, Table 3 In this study, we examined (1) reasons for and barriers to HIV testing among a national sample of A/PI MSM and (2) care and treatment among those who tested HIV-positive. Although we used a purposive convenience sample, the diversity of the study sites, including cities with the largest A/PI populations, gives credence to these findings. Several demographic characteristics differentiated non-U.S.-born from U.S.born A/PI MSM, including residence and geographic region of origin, as well as, to some extent, their age at first intimate sexual contact with another man and health-care access. However, our sample size did not allow us to further explore differential effects on HIVrelated issues due to nativity.
Combining those who self-reported ever having been tested for HIV but who did not know their HIV status (n536) and those who had never been tested for HIV (n535) resulted in a finding of almost 16% of participants not knowing their status, which was slightly better than the overall national estimate of 21%, but much better than the A/PI estimate of 30%. 25 It should be noted that our sample was recruited from CBOs that were familiar with or had extensive experience with HIV prevention targeting A/PIs; the estimate of unknown HIV status (16%) may be an underestimate of the general A/PI MSM population as a whole.
Research by Ross et al. provides a possible explanation for the somewhat unexpected finding of the few who self-reported being HIV-positive but screened HIVnegative. They interviewed one of their subjects who self-reported being positive but tested negative and, according to the authors, "This individual indicated he had understood a 'positive' result to mean a good result; that is, no evidence of HIV infection, in the sense of colloquial English rather than serology, suggests that this misunderstanding may be the source of the significant inaccuracy in self-report." 23 Unlike Ross et al., we did not conduct qualitative interviews with our participants; however, given that more than half of the sample was non-U.S.-born, the possibility that language may have played a role in the participants' misunderstanding of the survey is not too farfetched.
Perhaps the most important findings pertained to (1) reasons/barriers and (2) care/treatment. Perception of risks (e.g., risk for contracting HIV) was the major reason for engagement or nonengagement of HIV testing, a finding that is consistent with the literature. 17 This finding underscores the importance of reinforcing the message of safer practices, including regular HIV testing.
Structural barriers (e.g., "I don't know where to get tested") were also found to be major obstacles for naïve testers. Consistent with research by Do et al., 21 knowledge of testing sites was associated with HIV testing behavior. Given that we are in the third decade of the HIV epidemic, the fact that a portion of naïve testers still cited lack of knowledge of how to access HIV testing is a cause for alarm. Compounding this finding, some naïve testers cited not being able to afford to get tested as a structural barrier, indicating that there is perhaps a misconception about costs among some participants, as many HIV testing sites offer free or low-cost testing. 26 Individuals who had never been tested also cited fear of disclosure as a deterrent to HIV testing. It seems that letting families and friends know about their HIV status and/or sexual orientation may be reasons for participants' hesitancy to test. Meanwhile, for those non-U.S.-born MSM who might be undocumented (we did not inquire about citizenship in the study), potential government or job surveillance might be a deterrent for taking an HIV test via a standard channel (e.g., a public health clinic). Perhaps our research study based in the A/PI community may have been perceived as a safe environment for these non-U.S.-born individuals to find out their HIV status. Obermeyer and Osborn argued that ". . . conditions under which testing is administered document the effect of providerclient interactions on the utilization of testing. Clients' responses are influenced by providers' background characteristics (such as gender or ethnic group), attitudes, and perseverance and the extent to which they are trusted by their clients." 20 Findings on engagement in care and treatment were more complex. Due to the small sample size, none of the statistical comparisons by nativity were significant. Nonetheless, the fact that a sizable proportion of HIVpositive individuals was not being seen by a doctor (22%), not on HIV medication (19%), or both (17%) is a major public health concern. Collectively, these statistics suggest that knowing one's HIV status (via VCT) is only a beginning, and that other psychosocial determinants need to be examined to promote early care and treatment, as well as compliancy.
CoNCLUSIoNS
These findings are timely, as prominent international public health entities such as the IAS, Centers for Disease Control and Prevention, and National Institutes of Health all argue for the efficacy or effectiveness of the "Seek, Test, and Treat" (also known as Seek and Treat) paradigm, based on "mathematical modeling approaches" 27 as a form of HIV prevention. This study further contributes to a much needed, but sorely lacking, debate with empirical evidence to reassess this broad-based HIV prevention initiative with a critical lens. 18 Four major public health implications pertain to HIV VCT from these collective findings. First, the fact that three individuals self-reported being HIV-positive but tested negative underscores the importance of knowing one's status via an objective measure (i.e., testing). Second, risk perception (i.e., lack of it among those who had never been tested or having risks among those who had ever been tested) continues to speak to the importance of the necessity of basic HIV testing education. Third, removing structural barriers (e.g., having more convenient hours) should be a priority for reaching out to vulnerable or underserved populations, including MSM of Asian descent. Fourth, for those who have never been tested for HIV, fear of disclosure (and, by extension, stigma) continues to be an obstacle for testing, a finding that still resonates from research conducted more than a decade ago. 16 We argue that the public health benefit of a mechanical or biological implementation of the paradigm of VCT would be less than optimal without the inclusion of appropriate sociocultural components (e.g., reducing stigma and improving health-seeking among non-U.S.-born individuals), especially among racial/ethnic minority groups and/or marginalized populations.
